Filter
47
Filtered Results: 47
Text search:
pharmacovigilance
policy
handbook
Featured
Recommendations
11
Language
Document type
No document type
28
Guidelines
9
Manuals
6
Studies & Reports
2
Strategic & Response Plan
2
Countries / Regions
Eastern Europe
4
Russia
3
India
3
Kenya
2
Western and Central Europe
2
Ukraine
1
Ghana
1
Nigeria
1
Zimbabwe
1
Latin America and the Carribbean
1
Tanzania
1
South Africa
1
Uganda
1
Georgia
1
Zambia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
8
TB
7
Policies & Guidelines HIV & TB
5
Guidelines
4
Malaria
4
NTDs & Others
3
Taeniasis/ Cysticercosis
2
Leprosy
2
Hepatitis
1
Helminthiasis
1
Pharmacy & Technology
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
Vaccine-preventable Diseases
1
Clinical Guidelines
1
Studies & Reports
1
General Guidelines
1
Communicable Diseases
1
HIV & STI
1
Key Resources
1
Toolboxes
Drug resistant TB
8
Adults
3
Children
2
International
2
Pharmacy Practice
2
Rational use of Medicine
2
Clinical Guidelines
1
Childhood TB
1
Clinical Guidelines
1
Country specific
1
WPRO (Western Pacific Region)
1
Public Health
1
Georgia
1
Reports
1
Russia
1
Clinical Guidelines
1
Health Personnel
1
General
1
Essential Medicines & Devices Lists
1
General Guidelines for Rational Use
1
Diagnosis
1
Neurological Disorders
1
Training
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Western & Central Europe
1
Antiretroviral Treatment ART
1
TB
1
Eastern Europe & Central Asia
1
Meningitis & Encephalitis
1
SEAR (South-east Asia Region)
1
Treatment & Clinical Management
1
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Recommendations for a public health approach
2010 revision
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
Framework for implementation.
The END TB Strategy.
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
Ce glossaire actualisé sur le paludisme vise à améliorer la communication et la compréhension mutuelle au sein de la communauté scientifique, ainsi qu'avec les organismes de financement, les responsables de la santé publique chargés des programmes de lutte contre le paludisme et les décideur...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
